drug discovery

Home/Tag: drug discovery

Safety Pharmacology Society Annual Meeting (2020)

2020-08-20T14:06:05+00:00

Metrion Biosciences look forward to attending, presenting posters and exhibiting at the Virtual Safety Pharmacology Society (SPS) Annual Meeting to be held from 14th to 17th September 2020. Metrion will be located at Booth # 400 in the exhibits hall for the duration of the virtual event. Our collaborative poster with Nanion Technologies will be [...]

Safety Pharmacology Society Annual Meeting (2020)2020-08-20T14:06:05+00:00

An Interview with Damian Bell by Artem Kondratskyi

2020-07-19T18:36:26+00:00

Introducing Damian Bell: as a new member of the team at Metrion we are using an abridged version of an interview by Artem Kondratskyi for ionchannellibrary.com. A big thank you to Artem for sharing this interview and a quick plug for his website – we highly recommend it as an excellent resource for anyone [...]

An Interview with Damian Bell by Artem Kondratskyi2020-07-19T18:36:26+00:00

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines

2020-05-11T12:31:08+00:00

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines Part of the US FDA’s Comprehensive in vitro Proarrythmia Assay (CiPA) Initiative Cambridge, UK, 07 April 2020: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today [...]

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines2020-05-11T12:31:08+00:00

Metrion-Nanion Collaborative Webinar: Validation and optimisation of automated patch clamp voltage-gated Ca2+ channel assays

2020-04-10T19:04:07+00:00

Metrion Biosciences and Nanion Technologies look forward to hosting their first collaborative webinar on Tuesday 28th April entitled: Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays. The webinar will feature Metrion's CSO Dr. Marc Rogers. Marc will outline the development, optimisation and validation of a range of voltage-gated Ca2+ channel assays on [...]

Metrion-Nanion Collaborative Webinar: Validation and optimisation of automated patch clamp voltage-gated Ca2+ channel assays2020-04-10T19:04:07+00:00

RSC Ion Channel Symposium

2019-07-29T15:39:14+00:00

Metrion Biosciences are sponsoring and exhibiting (booth number to be added at a later date) at the RSC Ion Channel Symposium taking place from Monday 24th- Tuesday 25th February 2020 at the Wellcome Trust Genome Campus Conference Centre, Hinxton, Cambridge. Metrion will also be presenting a poster (title to be added at a later date). [...]

RSC Ion Channel Symposium2019-07-29T15:39:14+00:00

64th Annual Meeting of the Biophysical Society

2020-01-27T17:12:30+00:00

Metrion Biosciences will be attending and exhibiting at the 64th Annual Meeting of the Biophysical Society to be held at the San Diego Convention Centre in San Diego, California from 15th - 19th February 2020. Metrion will be exhibiting at booth number 214 in the Exhibits Hall for the duration of the meeting and will [...]

64th Annual Meeting of the Biophysical Society2020-01-27T17:12:30+00:00

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration

2019-12-03T08:32:31+00:00

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research Initial twelve month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimisation phase Cambridge and London, UK, 03 December 2019: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical [...]

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration2019-12-03T08:32:31+00:00

Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery

2020-03-04T09:13:21+00:00

Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special symposium at the ELRIG Drug Discovery 2019 conference yesterday, focused on the importance of targeting ion channels for drug discovery.  As a unique platform to foster the [...]

Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery2020-03-04T09:13:21+00:00

ELRIG Drug Discovery 2019

2019-11-01T15:02:04+00:00

Metrion Biosciences will be attending ELRIG Drug Discovery 2019 to be held at the ACC Arena, Liverpool on 5th and 6th November 2019. Dr Marc Rogers, Chief Scientific Officer, will be presenting an ion channel drug discovery focused talk at 12.10-12.30 during the British Pharmacology Society track 'Targeting Ion Channels for Drug Discovery" which takes [...]

ELRIG Drug Discovery 20192019-11-01T15:02:04+00:00

BioWednesday Cambridge: Joint One Nucleus and BioMed Realty Autumn Social

2019-09-10T15:55:07+00:00

Sales and Marketing Manager Dr Sophie Rose will be attending the joint One Nucleus and BioMed Realty social event to be held at Granta Park at the Apiary on 16th October 2019. Sophie will be available during the networking reception to discuss Metrion's range of ion channel screening services. If you would like to arrange [...]

BioWednesday Cambridge: Joint One Nucleus and BioMed Realty Autumn Social2019-09-10T15:55:07+00:00
Go to Top